ResArginTM, a conjugate of resveratrol and arginine, prevents memory impairment and oxidative stress in the Alzheimer’s disease rat model intoxicated with aluminum chloride
Background: Effective drugs for the prevention and treatment of Alzheimer's disease (AD) remain scarce. Antioxidant compounds are increasingly being explored for their anti-Alzheimer’s potential. This has led to the inclusion of up to three compounds in the 2023 Alzheimer's drug development pipeline for phase 3 trials...